Gilman Hill Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Gilman Hill Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$221.42 - $260.97 $226,955 - $267,494	-1,025 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$177.01 - $223.45 $181,435 - $229,036	1,025 New	1,025 $225,000
Q3 2020 Oct 16, 2020	SELL	$255.65 - $303.1 $178,955 - $212,170	-700 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$225.48 - $295.8 $157,836 - $207,060	700 New	700 $203,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Gilman Hill Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gilman Hill Asset Management, LLC with notifications on news.